[1]
|
孙方彪. 乙肝免疫球蛋白联合乙肝疫苗对母婴乙肝病毒传播的防治[J]. 中国卫生标准管理, 2020, 11(20): 12-14.
|
[2]
|
中国肝炎防治基金会, 中华医学会感染病学分会, 中华医学会肝病学分会. 阻断乙型肝炎病毒母婴传播临床管理流程(2021年) [J]. 中华传染病杂志, 2021, 39(3): 6.
|
[3]
|
Vittal, A. and Ghany, M. (2019) WHO Guidelines for Prevention, Care and Treatment of Individuals Infected with HBV: A US Perspective. Clinics in Liver Disease, 23, 417-432. https://doi.org/10.1016/j.cld.2019.04.008
|
[4]
|
吴维东, 李勤, 漆莉, 赵寒, 李柏松, 杨琳, 王菊, 等. 2016-2020年重庆市乙型病毒性肝炎时空流行特征分析[J]. 疾病监测, 2021(37): 1-6.
|
[5]
|
王崇. 乙型肝炎病毒母婴传播的阻断及免疫阻断失败母子病毒准种的检测[D]: [博士学位论文]. 长春: 吉林大学, 2017.
|
[6]
|
Lumley, S.F., Mcnaughton, A.L., Paul, K., Lythgoe, K.A. and Matthews, P.C. (2018) Hepatitis B Virus Adaptation to the CD8+ T Cell Response: Consequences for Host and Pathogen. Frontiers in Immunology, 9, Article No. 1561.
https://doi.org/10.3389/fimmu.2018.01561
|
[7]
|
Isogawa, M. and Tanaka, Y. (2015) Immunobiology of Hepatitis B Virus Infection. Hepatology Research, 45, 179-189.
https://doi.org/10.1111/hepr.12439
|
[8]
|
姚耀, 刘建波, 柴梅. HLA复合体与HBV感染及转归的关系[J]. 现代中西医结合杂志, 2018, 27(27): 5.
|
[9]
|
Robinson, J., Halliwell, J., Hayhurst, J., Flicek, P., Parham, P. and Marsh, S. (2015) The IPD and IMGT/HLA Database: Allele Variant Databases. Nucleic Acids Research, 43, D423-D431. https://doi.org/10.1093/nar/gku1161
|
[10]
|
Zheng, Z. (2014) Human Genes Involved in Hepatitis B Virus Infection. World Journal of Gastroenterology, 20, 7696-7706. https://doi.org/10.3748/wjg.v20.i24.7696
|
[11]
|
张海燕, 袁福兵, 周学士, 吴桂香, 戴亚新, 徐满琴. HLA-DRB1基因多态性与HBV感染的关联性[J]. 中华医院感染学杂志, 2021, 31(18): 2730-2733.
|
[12]
|
黄歆. HLA基因遗传变异与儿童乙肝感染的流行病学研究[D]: [硕士学位论文]. 重庆: 重庆医科大学, 2016.
|
[13]
|
姚琳, 佘芹, 尹玉竹. HBV母婴阻断失败儿童的HLA基因多态性研究——附12例报告[J]. 新医学, 2018, 49(5): 341-345.
|
[14]
|
Iannacone, M. and Guidotti, L. (2021) Immunobiology and Pathogenesis of Hepatitis B Virus Infection. Nature Reviews Immunology, 22, 19-32. https://doi.org/10.1038/s41577-021-00549-4
|
[15]
|
Guidotti, L.G. and Chisari, F.V. (2006) Immunobiology and Pathogenesis of Viral Hepatitis. Annual Review of Pathology, 1, 23-61. https://doi.org/10.1146/annurev.pathol.1.110304.100230
|
[16]
|
Hu, Z., Liu, Y., Zhai, X., Dai, J. and Shen, H. (2013) New Loci Associated with Chronic Hepatitis B Virus Infection in Han Chinese. Nature Genetics, 45, 1499-1503. https://doi.org/10.1038/ng.2809
|
[17]
|
Zhu, M., Dai, J., Wang, C., Wang, Y., Qin, N., Ma, H., Song, C., Zhai, X., Yang, Y. and Liu, J. (2016) Fine Mapping the MHC Region Identified Four Independent Variants Modifying Susceptibility to Chronic Hepatitis B in Han Chinese. Human Molecular Genetics, 25, 1225-1232. https://doi.org/10.1093/hmg/ddw003
|
[18]
|
O’Brien, K. and Pfeiffer, M. (2011) Risk Alleles for Chronic Hepatitis B Are Associated with Decreased mRNA Expression of HLA-DPA1 and HLA-DPB1 in Normal Human Liver. Genes & Immunity, 12, 428-433.
https://doi.org/10.1038/gene.2011.11
|
[19]
|
Zhang, D., Cheng, L., Badner, J.A., Chen, C., Chen, Q., Luo, W., Craig, D.W., Redman, M., Gershon, E.S. and Liu, C. (2010) Genetic Control of Individual Differences in Gene-Specific Methylation in Human Brain. The American Journal of Human Genetics, 86, 411-419. https://doi.org/10.1016/j.ajhg.2010.02.005
|
[20]
|
Pisaturo, M., Di Caprio, G., Calò, F., Portunato, F., Martini, S. and Coppola, N. (2018) Management of HBV Reactivation in Non-Oncological Patients. Expert Review of Anti-Infective Therapy, 16, 611-624.
https://doi.org/10.1080/14787210.2018.1505501
|
[21]
|
Matsuda, H., Hiramatsu, K., Akazawa, Y., Nosaka, T., Saito, Y., Ozaki, Y., Hayama, R., Takahashi, K., Naito, T. and Ofuji, K. (2018) Genetic Polymorphism and Decreased Expression of HLA Class II DP Genes Are Associated with HBV Reactivation in Patients Treated with Immunomodulatory Agents. Journal of Medical Virology, 90, 712.
https://doi.org/10.1002/jmv.25011
|